Takeaways from the most recent news in the technology and policies shaping healthcare.
CMS rules, legislation, and federal and state policy shaping how care is paid for and delivered, translated into what it means for the organizations that comply.
A federal judge struck down Trump's $100,000 H-1B visa fee as an unlawful tax, a win for hospitals that rely on foreign-trained physicians.
Why it matters: Hospitals depend on H-1B visas to recruit foreign-trained doctors, especially in rural and underserved areas, so the fee could have worsened staffing shortages.
HHS affordability czar Casey Mulligan says distorted incentives like provider taxes, not coverage gaps, are the root of high US healthcare costs.
Why it matters: The framing signals federal scrutiny of Medicaid financing tools that hospitals and states depend on, with potential ripple effects for payers and employers.
A leader of the 2014 U.S. Ebola response says the country is far less prepared for outbreaks today after the dismantling of USAID.
Why it matters: Global outbreak response depends on experienced personnel and funding pipelines that the U.S. has largely dismantled, leaving the world more exposed when the next emergency hits.
STAT News details how vaccines and treatments have transformed Ebola response since the 2014-2016 outbreak, alongside news on a suppressed alcohol report and wearables data.
Why it matters: Licensed vaccines and therapeutics mean future Ebola outbreaks can be contained faster, reshaping global preparedness and the economics of response.
The NIH appointed researcher John Powers III as acting director of NIAID, replacing Jeffery Taubenberger after weeks of leadership uncertainty.
Why it matters: NIAID funds much of the nation's infectious disease and vaccine research, so its leadership shapes pandemic preparedness and federal science priorities.
The VA deployed Oracle Health's EHR at four Ohio and Kentucky medical centers, its second 2026 wave after years of pauses to fix technical and safety issues.
Why it matters: The rollout tests whether one of the federal government's largest and most troubled health IT projects is finally back on track.
The FDA approved bemotrizinol, the first new sunscreen ingredient for the U.S. market in over 25 years, narrowing a gap with Europe and Asia.
Why it matters: It signals the FDA may finally be clearing a long backlog of modern sunscreen ingredients available abroad but not in the U.S.
Trump's health care affordability czar is targeting hospitals as cost drivers while backing Medicaid cuts, per STAT News.
Why it matters: Hospital pricing and Medicaid funding sit at the heart of US health costs, and federal pressure on both could reshape provider finances.